...
首页> 外文期刊>Journal of International Medical Research >A Multicentre General Practice Study to Compare Psoradrate 0.1% and Dithrocream 0.1% in the Treatment of Chronic Psoriasis
【24h】

A Multicentre General Practice Study to Compare Psoradrate 0.1% and Dithrocream 0.1% in the Treatment of Chronic Psoriasis

机译:多中心综合实践研究比较0.1%的甲磺酸和0.1%的双硫脂治疗慢性牛皮癣

获取原文
           

摘要

A multicentre general practice study was undertaken to compare the efficacy of two proprietary dithranol preparations, Psoradrate 0.1% and Dithrocream 0.1%, in the treatment of chronic psoriasis, using a single-blind, within-patient trial design. A total of forty-nine patients entered the study and treatment lasted for 6 weeks. Psoradrate 0.1% produced a greater mean per cent clinical improvement in psoriasis than Dithrocream 0.1% at each stage of the trial, and this difference was statistically significant (p = 0.025) at 4 weeks. The evidence also suggested that Psoradrate 0.1% resulted in greater reductions in psoriatic scaling. Most patients found that the Psoradrate 0.1% was more effective and a significant majority (p=0.01) thought that it worked faster than Dithrocream 0.1%. Although the increased effectiveness of the Psoradrate 0.1% was associated with a higher incidence of stinging/burning of the skin, this was not reflected in the patients' overall opinions of the treatments. Twenty-three patients preferred Psoradrate as against seventeen who preferred Dithrocream.
机译:进行了一项多中心的一般实践研究,以单盲患者内试验设计比较两种专有的二乙醇胺制剂(Psoradrate 0.1%和Dithrocream 0.1%)在治疗慢性牛皮癣中的功效。共有49位患者进入研究,治疗持续了6周。在试验的每个阶段,0.1%的Psoradrate产生的银屑病临床平均改善率均高于Dithrocream 0.1%的平均改善率,并且在4周时,该差异具有统计学意义(p = 0.025)。证据还表明,Psoradrate 0.1%导致银屑病结垢的更大程度降低。大多数患者发现0.1%的Psoradrate更有效,并且大多数患者(p = 0.01)认为它的作用比0.1%的Dithrocream更快。尽管0.1%的Psoradrate的有效性提高与皮肤刺痛/灼伤的发生率更高相关,但这并未反映在患者对治疗的总体看法中。 23名患者首选Psoradrate,而17名患者首选Dithrocream。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号